• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多状态模型预测比利时住院患者的新冠疫情进展情况。

Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model.

作者信息

Mertens Elly, Serrien Ben, Vandromme Mathil, Peñalvo José L

机构信息

Unit of Non-Communicable Diseases, Department of Public Health, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

出版信息

Front Med (Lausanne). 2022 Nov 23;9:1027674. doi: 10.3389/fmed.2022.1027674. eCollection 2022.

DOI:10.3389/fmed.2022.1027674
PMID:36507535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9727386/
Abstract

OBJECTIVES

To adopt a multi-state risk prediction model for critical disease/mortality outcomes among hospitalised COVID-19 patients using nationwide COVID-19 hospital surveillance data in Belgium.

MATERIALS AND METHODS

Information on 44,659 COVID-19 patients hospitalised between March 2020 and June 2021 with complete data on disease outcomes and candidate predictors was used to adopt a multi-state, multivariate Cox model to predict patients' probability of recovery, critical [transfer to intensive care units (ICU)] or fatal outcomes during hospital stay.

RESULTS

Median length of hospital stay was 9 days (interquartile range: 5-14). After admission, approximately 82% of the COVID-19 patients were discharged alive, 15% of patients were admitted to ICU, and 15% died in the hospital. The main predictors of an increased probability for recovery were younger age, and to a lesser extent, a lower number of prevalent comorbidities. A patient's transition to ICU or in-hospital death had in common the following predictors: high levels of c-reactive protein (CRP) and lactate dehydrogenase (LDH), reporting lower respiratory complaints and male sex. Additionally predictors for a transfer to ICU included middle-age, obesity and reporting loss of appetite and staying at a university hospital, while advanced age and a higher number of prevalent comorbidities for in-hospital death. After ICU, younger age and low levels of CRP and LDH were the main predictors for recovery, while in-hospital death was predicted by advanced age and concurrent comorbidities.

CONCLUSION

As one of the very few, a multi-state model was adopted to identify key factors predicting COVID-19 progression to critical disease, and recovery or death.

摘要

目的

利用比利时全国范围内的新冠病毒住院监测数据,采用多状态风险预测模型来预测新冠病毒住院患者的重症疾病/死亡结局。

材料与方法

收集了2020年3月至2021年6月期间住院的44659例新冠病毒患者的信息,这些患者具有完整的疾病结局数据和候选预测指标,采用多状态多变量Cox模型来预测患者在住院期间康复、重症(转入重症监护病房)或死亡的概率。

结果

住院时间中位数为9天(四分位间距:5 - 14天)。入院后,约82%的新冠病毒患者存活出院,15%的患者转入重症监护病房,15%的患者在医院死亡。康复概率增加的主要预测因素是年龄较小,其次是并存疾病数量较少。患者转入重症监护病房或院内死亡的共同预测因素如下:高水平的C反应蛋白(CRP)和乳酸脱氢酶(LDH)、有下呼吸道症状以及男性。此外,转入重症监护病房的预测因素还包括中年、肥胖、有食欲减退症状以及在大学医院就诊,而高龄和并存疾病数量较多则是院内死亡的预测因素。在转入重症监护病房后,年龄较小以及CRP和LDH水平较低是康复的主要预测因素,而高龄和并存疾病则是院内死亡的预测因素。

结论

作为极少数研究之一,采用了多状态模型来确定预测新冠病毒进展为重症疾病、康复或死亡的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/d61becb0696f/fmed-09-1027674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/023fb757b92f/fmed-09-1027674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/a8af2657a6dc/fmed-09-1027674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/150c22d93105/fmed-09-1027674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/d61becb0696f/fmed-09-1027674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/023fb757b92f/fmed-09-1027674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/a8af2657a6dc/fmed-09-1027674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/150c22d93105/fmed-09-1027674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d73a/9727386/d61becb0696f/fmed-09-1027674-g004.jpg

相似文献

1
Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model.基于多状态模型预测比利时住院患者的新冠疫情进展情况。
Front Med (Lausanne). 2022 Nov 23;9:1027674. doi: 10.3389/fmed.2022.1027674. eCollection 2022.
2
Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium.探讨 ACEIs/ARBs 使用与 COVID-19 预后的关系:来自比利时全国医院监测数据的多状态建模研究。
BMJ Open. 2021 Sep 16;11(9):e053393. doi: 10.1136/bmjopen-2021-053393.
3
4
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
5
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.新冠肺炎危重症患者的多系统结局和死亡率预测因素:人口统计学和疾病严重程度比合并症或治疗方式更重要。
J Trauma Acute Care Surg. 2021 May 1;90(5):880-890. doi: 10.1097/TA.0000000000003085.
6
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者:快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
7
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
8
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.随机临床试验评估 COVID-19 住院患者使用恢复期血浆的安全性和疗效(PERUCONPLASMA):一项随机对照试验研究方案的结构化总结。
Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.
9
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.
10
Difference in determinants of ICU admission and death among COVID-19 hospitalized patients in two epidemic waves in Portugal: possible impact of healthcare burden and hospital bed occupancy on clinical management and outcomes, March-December 2020.葡萄牙两波 COVID-19 住院患者 ICU 入院和死亡的决定因素差异:医疗负担和病床占用对临床管理和结局的可能影响,2020 年 3 月至 12 月。
Front Public Health. 2023 Jun 29;11:1215833. doi: 10.3389/fpubh.2023.1215833. eCollection 2023.

引用本文的文献

1
Circadian rest-activity rhythms and multimorbidity and mortality risks among menopausal women: a trajectory analysis of a UK Biobank cohort.绝经后女性的昼夜休息-活动节律与多种疾病及死亡风险:英国生物银行队列的轨迹分析
BMC Public Health. 2025 Apr 7;25(1):1304. doi: 10.1186/s12889-025-22536-3.
2
Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model.使用多状态模型预测库尔德斯坦省住院患者的COVID-19病情进展。
J Diabetes Metab Disord. 2025 Mar 22;24(1):88. doi: 10.1007/s40200-025-01576-x. eCollection 2025 Jun.
3
Post-discharge all-cause mortality in COVID-19 recovered patients hospitalized in 2020: the impact of chronic kidney disease.

本文引用的文献

1
The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium.组织特征对比利时入住重症监护病房的COVID-19患者治疗结果的影响。
Lancet Reg Health Eur. 2020 Dec 23;2:100019. doi: 10.1016/j.lanepe.2020.100019. eCollection 2021 Mar.
2
Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain).从诊断到康复或死亡预测 COVID-19 的进展:将卡斯蒂利亚-莱昂(西班牙)的初级保健和医院记录联系起来。
PLoS One. 2021 Sep 20;16(9):e0257613. doi: 10.1371/journal.pone.0257613. eCollection 2021.
3
Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium.
2020 年住院的 COVID-19 康复患者出院后的全因死亡率:慢性肾脏病的影响。
Rev Inst Med Trop Sao Paulo. 2024 Jan 5;66:e1. doi: 10.1590/S1678-9946202466001. eCollection 2024.
4
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19.住院早期的CRP监测:对预测COVID-19患者预后的意义
Pathogens. 2023 Nov 4;12(11):1315. doi: 10.3390/pathogens12111315.
探讨 ACEIs/ARBs 使用与 COVID-19 预后的关系:来自比利时全国医院监测数据的多状态建模研究。
BMJ Open. 2021 Sep 16;11(9):e053393. doi: 10.1136/bmjopen-2021-053393.
4
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.既往健康状况与严重 COVID-19 结局:全球证据的伞式评价方法和荟萃分析。
BMC Med. 2021 Aug 27;19(1):212. doi: 10.1186/s12916-021-02058-6.
5
Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?我们能否预测 COVID-19 的严重病程——临床结局指标的系统评价和荟萃分析?
PLoS One. 2021 Jul 29;16(7):e0255154. doi: 10.1371/journal.pone.0255154. eCollection 2021.
6
Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis.与 COVID-19 重症患者死亡率相关的因素:系统评价和荟萃分析。
Anaesthesia. 2021 Sep;76(9):1224-1232. doi: 10.1111/anae.15532. Epub 2021 Jun 29.
7
Prediction of hospital bed capacity during the COVID- 19 pandemic.2019冠状病毒病大流行期间医院床位容量的预测
BMC Health Serv Res. 2021 May 18;21(1):468. doi: 10.1186/s12913-021-06492-3.
8
Smoking and risk of COVID-19 hospitalization.吸烟与 COVID-19 住院风险。
Respir Med. 2021 Jun;182:106414. doi: 10.1016/j.rmed.2021.106414. Epub 2021 Apr 17.
9
Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis.吸烟史与COVID-19患者严重及危重结局的关联:一项系统评价与荟萃分析。
Eur J Integr Med. 2021 Apr;43:101313. doi: 10.1016/j.eujim.2021.101313. Epub 2021 Feb 18.
10
Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication.COVID-19 住院患者的吸烟流行率及其与疾病严重程度和死亡率的关系:对近期出版物的扩展再分析。
Harm Reduct J. 2021 Jan 16;18(1):9. doi: 10.1186/s12954-020-00437-5.